Literature DB >> 9229990

[New muscle relaxants. Update on mivacurium, rocuronium and cis-atracurium].

T Fuchs-Buder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9229990     DOI： 10.1007/s001010050411

Source DB:  PubMed          Journal:  Anaesthesist        ISSN： 0003-2417            Impact factor:   1.041


× No keyword cloud information.
  16 in total

1.  The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.

Authors:  J J Savarese; H H Ali; S J Basta; P B Embree; R P Scott; N Sunder; J N Weakly; W B Wastila; H A el-Sayad
Journal:  Anesthesiology       Date:  1988-05       Impact factor: 7.892

2.  Intubating conditions following 1R CIS, 1'R CIS atracurium (51W89). A comparison with atracurium.

Authors:  I H Littlejohn; K Abhay; A el Sayed; C J Broomhead; P Duvaldestin; P J Flynn
Journal:  Anaesthesia       Date:  1995-06       Impact factor: 6.955

Review 3.  [Modern muscle relaxants and their clinical application].

Authors:  H Mellinghoff
Journal:  Anaesthesist       Date:  1994-04       Impact factor: 1.041

4.  Influence of induction technique on intubating conditions after rocuronium in adults: comparison with rapid-sequence induction using thiopentone and suxamethonium.

Authors:  H J Sparr; S Giesinger; H Ulmer; M Hollenstein-Zacke; T J Luger
Journal:  Br J Anaesth       Date:  1996-09       Impact factor: 9.166

5.  Intubating conditions and time course of rocuronium-induced neuromuscular block in children.

Authors:  T Fuchs-Buder; E Tassonyi
Journal:  Br J Anaesth       Date:  1996-09       Impact factor: 9.166

6.  Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure.

Authors:  D R Cook; J A Freeman; A A Lai; Y Kang; R L Stiller; S Aggarwal; J C Harrelson; R M Welch; B Samara
Journal:  Br J Anaesth       Date:  1992-12       Impact factor: 9.166

7.  Rocuronium (Org 9426) for caesarean section.

Authors:  E Abouleish; T Abboud; T Lechevalier; J Zhu; A Chalian; K Alford
Journal:  Br J Anaesth       Date:  1994-09       Impact factor: 9.166

Review 8.  Mivacurium chloride--a comparative profile.

Authors:  C Diffenbach; W Buzello; H Mellinghoff
Journal:  Acta Anaesthesiol Scand Suppl       Date:  1995

9.  Effect of renal function on neuromuscular block induced by continuous infusion of mivacurium.

Authors:  M Blobner; S Jelen-Esselborn; G Schneider; R Mann; M Kling; P Luppa; H J Schneck; E Kochs
Journal:  Br J Anaesth       Date:  1995-04       Impact factor: 9.166

10.  The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.

Authors:  C A Lien; M R Belmont; A Abalos; L Eppich; S Quessy; M M Abou-Donia; J J Savarese
Journal:  Anesthesiology       Date:  1995-05       Impact factor: 7.892
View more
  3 in total

Review 1.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  [Total intravenous anesthesia with propofol and remifentanil. Results of a multicenter study of 6,161 patients].

Authors:  J Schmidt; W Hering; S Albrecht
Journal:  Anaesthesist       Date:  2005-01       Impact factor: 1.041

3.  The median effective dose (ED50) of cis-Atracurium for laryngeal mask airway insertion during general Anaesthesia for patients undergoing urinary surgery.

Authors:  Xiaohua Wang; Ke Huang; Hao Yan; Fei Lan; Dongxu Yao; Yanhong Li; Jixiu Xue; Tianlong Wang
Journal:  BMC Anesthesiol       Date:  2020-03-19       Impact factor: 2.217
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.